ArticleBMJ (Clinical research ed.)1996
Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.
A Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.